이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Elevance Health 대차 대조표 상태
재무 상태 기준 확인 5/6
Elevance Health 의 총 주주 지분은 $40.7B 이고 총 부채는 $26.5B, 이는 부채 대 자기자본 비율을 65% 로 가져옵니다. 총자산과 총부채는 각각 $111.9B 및 $71.2B 입니다. Elevance Health 의 EBIT는 $10.2B 이며 이자보상배율은 9.8 입니다. $36.3B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
65.0%
부채 비율
US$26.45b
부채
| 이자 보상 비율 | 9.8x |
| 현금 | US$36.27b |
| 주식 | US$40.71b |
| 총 부채 | US$71.18b |
| 총 자산 | US$111.89b |
최근 재무 상태 업데이트
Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16
Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Recent updates
Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Does Elevance Health (NYSE:ELV) Deserve A Spot On Your Watchlist?
Nov 16Elevance Health to acquire speciality pharmacy from CarepathRx
Nov 09Elevance Health (NYSE:ELV) Is Doing The Right Things To Multiply Its Share Price
Nov 02Elevance Health declares $1.28 dividend
Oct 19Are Investors Undervaluing Elevance Health Inc. (NYSE:ELV) By 37%?
Oct 12Elevance affiliates to offer affordable Medicare Advantage plans
Oct 10재무 상태 분석
단기부채: ELV 의 단기 자산 ( $60.9B )이 단기 부채( $44.3B ).
장기 부채: ELV 의 단기 자산( $60.9B )이 장기 부채( $26.9B ).
부채 대 자본 내역 및 분석
부채 수준: ELV 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: ELV 의 부채 대 자기자본 비율은 지난 5년간 66.4% 에서 65% 로 감소했습니다.
부채 범위: ELV 의 부채는 영업 현금 흐름 ( 13.5% )에 의해 잘 갚지 않음입니다.
이자 보장: ELV 의 부채에 대한 이자 지급은 EBIT( 9.8 x 적용 범위)로 잘 충당됩니다.